Ilyang PharmaceuticalLtd Dividends and Buybacks
Dividend criteria checks 1/6
Ilyang PharmaceuticalLtd is a dividend paying company with a current yield of 1.19%. Next payment date is on 21st April, 2025 with an ex-dividend date of 27th December, 2024.
Key information
1.2%
Dividend yield
0%
Buyback Yield
| Total Shareholder Yield | 1.2% |
| Future Dividend Yield | n/a |
| Dividend Growth | 30.7% |
| Next dividend pay date | 21 Apr 25 |
| Ex dividend date | 27 Dec 24 |
| Dividend per share | ₩150.000 |
| Payout ratio | -365% |
Recent dividend and buyback updates
Recent updates
Ilyang Pharmaceutical Co.,Ltd's (KRX:007570) 28% Price Boost Is Out Of Tune With Revenues
Jan 06
Here's Why Ilyang PharmaceuticalLtd (KRX:007570) Has A Meaningful Debt Burden
Jan 03Is Ilyang PharmaceuticalLtd (KRX:007570) A Risky Investment?
Apr 04Should You Be Adding Ilyang PharmaceuticalLtd (KRX:007570) To Your Watchlist Today?
Mar 14Ilyang Pharmaceutical Co.,Ltd (KRX:007570) Shares May Have Slumped 36% But Getting In Cheap Is Still Unlikely
Mar 14Declining Stock and Decent Financials: Is The Market Wrong About Ilyang Pharmaceutical Co.,Ltd (KRX:007570)?
Feb 22Did Business Growth Power Ilyang PharmaceuticalLtd's (KRX:007570) Share Price Gain of 159%?
Feb 01Is Ilyang Pharmaceutical Co.,Ltd's (KRX:007570) Shareholder Ownership Skewed Towards Insiders?
Jan 11
Here's Why Ilyang PharmaceuticalLtd (KRX:007570) Can Manage Its Debt Responsibly
Dec 24A Look At The Intrinsic Value Of Ilyang Pharmaceutical Co.,Ltd (KRX:007570)
Dec 06Ilyang Pharmaceutical Co.,Ltd (KRX:007570) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future?
Nov 18Stability and Growth of Payments
Fetching dividends data
Stable Dividend: A007570 has been paying a dividend for less than 10 years and during this time payments have been volatile.
Growing Dividend: A007570's dividend payments have increased, but the company has only paid a dividend for 5 years.
Dividend Yield vs Market
| Ilyang PharmaceuticalLtd Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (A007570) | 1.2% |
| Market Bottom 25% (KR) | 1.2% |
| Market Top 25% (KR) | 3.9% |
| Industry Average (Pharmaceuticals) | 1.0% |
| Analyst forecast (A007570) (up to 3 years) | n/a |
Notable Dividend: A007570's dividend (1.19%) is higher than the bottom 25% of dividend payers in the KR market (1.18%).
High Dividend: A007570's dividend (1.19%) is low compared to the top 25% of dividend payers in the KR market (3.94%).
Earnings Payout to Shareholders
Earnings Coverage: A007570 is paying a dividend but the company is unprofitable.
Cash Payout to Shareholders
Cash Flow Coverage: A007570 is paying a dividend but the company has no free cash flows.
Discover strong dividend paying companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/08 16:17 |
| End of Day Share Price | 2025/01/08 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Ilyang Pharmaceutical Co.,Ltd is covered by 5 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Hyung Soo Kim | Cape Investment & Securities Co., Ltd. |
| Jae Hoon Shin | LS Securities Co., Ltd. |
| Jaechul Park | Mirae Asset Securities Co., Ltd. (Pre-Merger) |